Non-invasive Nerve Stimulation and Cognitive Training to Improve Cognitive Performance in Healthy Older Adults

Sponsor
University of Florida (Other)
Overall Status
Recruiting
CT.gov ID
NCT04276805
Collaborator
University of Arizona (Other), McKnight Brain Research Foundation (Other)
40
2
2
25
20
0.8

Study Details

Study Description

Brief Summary

We need better tools to both enhance brain health and improve cognitive performance in healthy brain aging so that it can be delayed, reduced, or even reversed. The present proposal is designed to evaluate the pairing of cognitive training with a non-invasive neurostimulation technology that has shown promise in both increasing neuroplasticity and in enhancing cognitive performance, transcutaneous vagal nerve stimulation (tVNS).

Condition or Disease Intervention/Treatment Phase
  • Device: Transcutaneous vagal nerve stimulation (tVNS)
  • Behavioral: cognitive training
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Basic Science
Official Title:
Non-invasive Nerve Stimulation and Cognitive Training to Improve Cognitive Performance in Healthy Older Adults
Actual Study Start Date :
Nov 17, 2020
Anticipated Primary Completion Date :
Dec 17, 2022
Anticipated Study Completion Date :
Dec 17, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: tVNS group

Participants will undergo cognitive training with tVNS

Device: Transcutaneous vagal nerve stimulation (tVNS)
a non-invasive and safe technique that transiently enhances brain GABA and noradrenaline levels.

Behavioral: cognitive training
A program of regular mental activities purported to maintain or improve one's cognitive abilities.

Sham Comparator: Sham group

Participants will undergo cognitive training with earlobe sham

Behavioral: cognitive training
A program of regular mental activities purported to maintain or improve one's cognitive abilities.

Outcome Measures

Primary Outcome Measures

  1. Change in working memory and processing speed contributors [Baseline to 2 weeks]

    The Posit Science BrainHQ

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Healthy individuals willing to commit to study requirements
Exclusion Criteria:
  • Neurological disorders to include traumatic brain injury.

  • Evidence of dementia .

  • Major psychiatric illness

  • Unstable and chronic medical conditions.

  • MRI contraindications (e.g., pregnancy, claustrophobia, metal implants that are contraindicated for MRI).

  • Physical impairment precluding motor response or lying still or walking

  • Hearing or vision deficits that will not allow for completion of assessments

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Arizona Tucson Arizona United States 85721
2 University of Florida Gainesville Florida United States 32610

Sponsors and Collaborators

  • University of Florida
  • University of Arizona
  • McKnight Brain Research Foundation

Investigators

  • Principal Investigator: John Williamson, PhD, University of Florida

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Florida
ClinicalTrials.gov Identifier:
NCT04276805
Other Study ID Numbers:
  • IRB201902991
First Posted:
Feb 19, 2020
Last Update Posted:
Jun 16, 2022
Last Verified:
Jun 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes

Study Results

No Results Posted as of Jun 16, 2022